Novel Coronavirus Pneumonia (COVID-19)
Conditions
Interventions
Control Group:Conventional Treatment
Sponsors
Shanghai Public Health Clinical Center
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: (1) Those who meet the diagnosis of new coronavirus pneumonia and have clinical classification of low and medium; (2) Those who have been diagnosed with TCM as epidemic-closed lungs; (3) Inpatients aged 18 to 75 years, regardless of gender; (4) Voluntarily receive treatment with the drug and sign informed consent. The informed consent process complies with relevant GCP regulations.
Exclusion criteria
Exclusion criteria: (1) Immunodeficiency disease, or those who have used immunosuppressive agents or glucocorticoids within the past 3 months; (2) Preparing pregnant, pregnant and lactating women; (3) Patients with allergies (referring to allergies to two or more medicines, foods or known ingredients in this study); (4) Patients with mental illness, or have no cognitive ability; (5) Patients with an estimated survival time of less than 48 hours from the start of screening; (6) Those who have been intubated or mechanically ventilated at the time of screening; (7) Obvious symptoms of heart, liver, kidney or various other systems, ALT, AST exceed 1.5 times the upper limit of normal value; (8) Believed to be not suitable to participate in clinical trials by investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Antipyretic time;Time of viral nucleic acid turns negative; | — |
Secondary
| Measure | Time frame |
|---|---|
| Clinical recovery time;Inflammation index (CRP);The disappearance rate and time of cough symptoms;Critical (severe or critical) conversion rate;Arterial Oxygen Saturation; | — |
Countries
China
Contacts
Public ContactHongzhou Lu, Xiaorong Chen
Shanghai Public Health Clinical Center
Outcome results
None listed